Physician profile
Scott Cohen
NPI 1700934817
$1,037.85
in general payments reported to CMS, 2019-2025
13 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.36 · 2020: $57.21 · 2021: $163 · 2022: $80.29 · 2023: $91.50 · 2024: $268 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $301.49 | 2019-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Welch Allyn | $145.66 | 2021 | |
| Sanofi-Aventis U.S. LLC | $143.83 | 2024-2025 | |
| Sanofi Pasteur INC. | $126.35 | 2019-2025 | |
| Pfizer INC. | $64.60 | 2020-2025 | |
| Neurelis, INC. | $48.20 | 2024-2025 | Valtoco |
| Verrica Pharmaceuticals INC. | $40.31 | 2024 | Ycanth |
| Regeneron Healthcare Solutions, INC. | $38.04 | 2024 | Dupixent |
| Glaxosmithkline, LLC. | $36.18 | 2025 | Bexsero, Rotarix, Penmenvy |
| Seqirus USA INC | $25.05 | 2023 | Flucelvax Quadrivalent |
| Alk-Abello, INC | $24.91 | 2025 | Neffy |
| Lnhc, INC | $22.98 | 2025 | Zelsuvmi |
| Organon LLC | $20.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.